Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Study Design: Single-center, not-randomized, open-label, two-arms controlled pilot clinical
trial.
Health Condition: Patients with severe trauma with a need for transfusion and categorized as
priority 0 or 1 according to the Catalan Health Service (CatSalut) Polytrauma Code (PPT)